Newborn Intravenous Injection of Liposomal CRISPR/Cas9 Complex Has No Incidence of Off-Targets or Tumors in Mice.
Saved in:
| Title: | Newborn Intravenous Injection of Liposomal CRISPR/Cas9 Complex Has No Incidence of Off-Targets or Tumors in Mice. |
|---|---|
| Authors: | Monteagudo, Vinícius1,2 (AUTHOR), Flores, Larissa Cristina Barbosa1,2 (AUTHOR), Lopes, Melaine1,2,3 (AUTHOR), Fachel, Flavia Nathiely Silveira1,4 (AUTHOR), Martins, Giselle1,2 (AUTHOR), Siebert, Marina2 (AUTHOR), Carniel, Willian da Silva1,2,3 (AUTHOR), Garcez, Tuane Nerissa Alves2,4 (AUTHOR), Teixeira, Helder Ferreira1 (AUTHOR), Matte, Ursula2,3 (AUTHOR), Giugliani, Roberto2,3 (AUTHOR), Baldo, Guilherme2,3 (AUTHOR), Poletto, Édina4 (AUTHOR), Schuh, Roselena Silvestri1,2 (AUTHOR) roselena.schuh@ufrgs.br |
| Source: | Pharmaceutics. May2025, Vol. 17 Issue 5, p656. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
